CCK-8 and flow cytometry results show that SLC39A1 promotes proliferation of glioma cells and inhibits their apoptosis; RT-qPCR and western blot results show that SLC39A1 promotes the progression of glioma by increasing the expression level of MMP2\MMP9 (Fig. 8). Here, MMP2 is linked to glioma.